Clinical trial
The Role of Amylin in Bone Metabolism
NCT06186063 is registered in ClinicalTrials.gov with Filip Krag Knop as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Amylin in Bone Metabolism
- Lead sponsor
- Filip Krag Knop
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 12, 2024
- Completion date
- August 1, 2024
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bone diseases, metabolic, type 1 diabetes